Results 111 to 120 of about 15,000 (182)

Recombinant human erythropoietin plus all-<i>trans</i> retinoic acid and testosterone undecanoate for the treatment of anemia in patients with lower-risk myelodysplastic syndromes: a multicenter, single-arm, prospective trial. [PDF]

Haematologica
Mei C, Xu G, Zheng C, Xie Y, Li M, Shao Y, Yao R, Tao S, Jiang W, Guo J, Zheng Z, Wang W, Zhou X, Ma L, Ye L, Luo Y, Yang C, Yu W, Xie W, Jin J, Tong H.   +20 more
europepmc   +1 more source

Recombinant human erythropoietin accelerated the proliferation of non-small cell lung cancer cell lines and reduced the expression of VEGF, HIF-1α, and PD-L1 under a simulated hypoxic environment in vitro. [PDF]

Chronic Dis Transl Med, 2022
Zhang Y, Feng Y, Sun X.
europepmc   +1 more source

Positive response of a hemodialysis patient with pure red cell aplasia on recombinant human erythropoietin therapy to cyclosporine and Roxadustat. [PDF]

CEN Case Rep
Ma X, Pai P, Zhu W, Chen X, Cui L.
europepmc   +1 more source

Effect of Early High-Dose Recombinant Human Erythropoietin on Behavior and Quality of Life in Children Aged 5 Years Born Very Preterm: Secondary Analysis of a Randomized Clinical Trial.

JAMA Netw Open, 2022
Picotti E, Reinelt T, Koller B, Bucher HU, Rüegger CM, Fauchère JC, Natalucci G, Swiss EPO Neuroprotection Trial Group.   +7 more
europepmc   +1 more source

Efficacy and safety of high and low dose recombinant human erythropoietin on neurodevelopment of premature infants: A meta-analysis.

Medicine (Baltimore), 2021
Qin N, Qin H.
europepmc   +1 more source

Angiogenic responses are enhanced by recombinant human erythropoietin in a model of periventricular white matter damage of neonatal rats through EPOR-ERK1 signaling. [PDF]

J Neuropathol Exp Neurol
Zhu L, Yuan Q, Jing C, Sun L, Jiang L.
europepmc   +1 more source

Clinical Indications of Recombinant Human Erythropoietin in a Single Center: A 10-Year Retrospective Study. [PDF]

Front Pharmacol, 2020
Guan XZ, Wang LL, Pan X, Liu L, Sun XL, Zhang XJ, Wang DQ, Yu Y.   +7 more
europepmc   +1 more source

Efficacy and safety of high and low dose recombinant human erythropoietin on neurodevelopment of premature infants: A meta-analysis: Retraction. [PDF]

Medicine (Baltimore)
europepmc   +1 more source

Effect of early prophylactic low-dose recombinant human erythropoietin on retinopathy of prematurity in very preterm infants. [PDF]

J Transl Med, 2020
Sun H, Song J, Kang W, Wang Y, Sun X, Zhou C, Xiong H, Xu F, Li M, Zhang X, Yu Z, Peng X, Li B, Xu Y, Xing S, Wang X, Zhu C.   +16 more
europepmc   +1 more source

The Efficacy and Safety of Enarodustat for the Treatment of Anemia in Hemodialysis-Dependent Chronic Kidney Disease Patients: A Phase 3, Multicenter, Randomized, Active-Comparator (Recombinant Human Erythropoietin), Open-Label Study - The ENARODIAL Study.

Am J Nephrol
Wu H, Ai Z, Liu A, Ye H, Sun C, Yang A, Chen W, Zheng Z, Wang C, Li Y, Cao N, Wang C, Xia Y, Cheng H, Luo P, Yang Q, Yan Y, Zhou H, Mao N, Xiong Z, Liu B, Hong D, Chen Q, Liang B, Luo Q, Wang Y, Shi Y, Chen X, Zhou L, Yan T, Zhu B, Wang J, Chen M, Zhu Y, Guan T, Wang S, Mu S, Chen Y, Lian X, Liu Z, Xu Y, Chen W.   +41 more
europepmc   +1 more source